HCA Healthcare, Inc. · NYSE:HCA
HCA Healthcare — Investor Presentation (2018)
17 slides from HCA Healthcare's investor presentation, 2018
Slide 1: Investor Update 2Q 2018
S) Medical City Dallas 2Q 2018 HCA
Slide 2: Forward Looking Statements and Non-GAAP Financial Measures
Forward Looking Statements and Non-GAAP Financial Measures This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looki
Slide 3: Diversified Mix of Facilities, Services, and Settings
Diversified Mix of Facilities, Services, and Settings Acute Ambulatory Access Physicians Care Services Centers 178 122 127 ~1,200 Hospitals ASCs Urgent Care Physician Centers Clinics 47k 16 79 ~38k Licensed GI FSERs Active Medical Beds Centers Staff * Figures as of June 30, 2018 03
Slide 4: Attractive and Diversified Asset Portfolio
Attractive and Diversified Asset Portfolio HCA has a significant presence in 16 of the top 25 U.S. MSAs with the strongest Economic Health Index Boise Salt Lake Denver Northern Kansas Virginia San City Southwest Jose Wichita Virginia Las Nashville Vegas Richmond Southern California Myrtle Savannah B
Slide 5: Strategic Guiding Principles
Strategic Guiding Principles Committed to industry leading quality & service Growth through patient & physician relationships Be the provider system of choice for patients and physicians by leveraging the A well-informed response to scale and capabilities of HCA the market environment in the local m
Slide 6: Strong Market Share
Strong Market Share 24.5% HCA market share ranks 1st or 2nd in 27 of 38 studied markets HCA’s Enterprise Market Share: 24.5% Salt Lake 19.9% Denver Northern 32.6% Kansas Virginia City 11.0% 21.8% SWVA Wichita San Jose 30.4% 37.6% 19.4% Las Nashville Vegas Richmond 35.0% 29.2% 37.6% Southern Californ
Slide 7: Consistent Top Line Growth
Consistent Top Line Growth Equivalent Admissions Admissions Revenue 5 year CAGR1 2.2% 5 year CAGR1 3.0% 5 year CAGR1 5.7% 20172 1.94M 20172 3.29M 20172 $43.6B 2018 YTD over PY3 4.5% 2018 YTD over PY3 4.9% 2018 YTD over PY3 7.5% Emergency Surgeries Room Visits 5 year CAGR1 1.4% 5 year CAGR1 4.5% 2017
Slide 8: Adjusted EBITDA & EPS Growth
Adjusted EBITDA & EPS Growth Adjusted EBITDA in Billions $8.4 $8.2B $7 $8.2 $5.95 $8.0 3.5% 12.7% $6 Diluted EPS $7.8 3 YR $5 $7.4B Adj CAGR $7.6 Diluted $4.16 $7.4 EBITDA EPS $4 $7.2 $7.0 $3 2014 2015 2016 2017 2014 2015 2016* 2017* Revised Guidance Adjusted EBITDA Diluted EPS $8.65B – $8.85B $9.00
Slide 9: Deploying a Balanced Allocation of Capital
Deploying a Balanced Allocation of Capital Delivering Investing Shareholder in Growth Value $17.1B $3.2B Capital Special Expenditures Dividends Cash Flow from $5.8B Operations $245M Acquisition Capital $34.0B Quarterly Dividends* $11.8B Share Cash Flows provided by Operations and primary uses of Cas
Slide 10: Provider System of Choice
Provider System of Choice Operational Excellence Coordination Across Access and Continuum Convenience Local Sustainable Growth Strong Comprehensive Physician Service Relationships Lines 10
Slide 11: Comprehensive Access Across the Continuum
Comprehensive Access Across the Continuum 3 Nashville, TN Market Hospital Campuses 13 5 Imaging Centers 21 Ambulatory Surgery Centers 4 3 Health Parks 7 TriStar Medical Group 2 2 7 Locations 59 5 3 Freestanding ERs 3 CareNow Urgent Care Centers 12 Transfer Center 1 Figures as of June 30, 2018 11
Slide 12: Sources of Differentiation
Sources of Differentiation Capital Improve Our Business Innovation Drive Growth Speed to Market Support Execution Economies 12
Slide 13: 2018 Pipeline: Committed to Ensuring Capacity and Access
Committed to Ensuring Capacity and Access $22.9B Invested Since the 2011 IPO Annual Capital Investment 2011** 2018 Pipeline* 2012 2013 558 2014 Inpatient Beds 2015 187 2016 2017 ER Beds June $1.57 $0.54 2018 YTD $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 $4.5 In Billions PP&E Acquisition * Project
Slide 14: Driving Value for Key Stakeholders
Driving Value for Key Stakeholders Patients Physicians Employees Payers Shareholders Comprehensive Clinical Compensation Network of Access Earnings Safe Capabilities and Benefits Points and Service Growth Lines High Quality Return on Efficient Place Training and Competitively Capital Compassionate t
Slide 15: Advancing the Patient Experience
Advancing the Patient Experience Strong Leadership Partnering with Patient Engaged Physicians Experience Employees Big Data/ Technology 15
Slide 16: Partnering with Physicians
Partnering with Physicians VOICE PHYSICIAN ENGAGEMENT TIME GROWTH CLINICAL CAPABILITIES 16
Slide 17: Sources of Differentiation
Sources of Differentiation Deep and Experienced Leadership Strong Diversified Portfolio Operating Culture Financial Scale Strength 17